Literature DB >> 15308694

Characterization of a highly pathogenic molecular clone of feline immunodeficiency virus clade C.

Sohela de Rozières1, Candace K Mathiason, Matthew R Rolston, Udayan Chatterji, Edward A Hoover, John H Elder.   

Abstract

We have derived and characterized a highly pathogenic molecular isolate of feline immunodeficiency virus subtype C (FIV-C) CABCpady00C. Clone FIV-C36 was obtained by lambda cloning from cats that developed severe immunodeficiency disease when infected with CABCpady00C (Abbotsford, British Columbia, Canada). Clone FIV-C36 Env is 96% identical to the noninfectious FIV-C isolate sequence deposited in GenBank (FIV-Cgb; GenBank accession number AF474246) (A. Harmache et al.) but is much more divergent in Env when compared to the subgroup A clones Petaluma (34TF10) and FIV-PPR (76 and 78% divergence, respectively). Clone FIV-C36 was able to infect freshly isolated feline peripheral blood mononuclear cells and primary T-cell lines but failed to productively infect CrFK cells, as is typical of FIV field isolates. Two-week-old specific-pathogen-free cats infected with FIV-C36 tissue culture supernatant became PCR positive and developed severe acute immunodeficiency disease similar to that caused by the uncloned CABCpady00C parent. At 4 to 5 weeks postinfection (PI), 3 of 4 animals developed CD4(+)-T-cell depletion, fever, weight loss, diarrhea, and opportunistic infections, including ulcerative stomatitis and tonsillitis associated with abundant bacterial growth, pneumonia, and pyelonephritis, requiring euthanasia. Histopathology confirmed severe thymic and systemic lymphoid depletion. Interestingly, the dam also became infected with a high viral load at 5 weeks PI of the kittens and developed a similar disease syndrome, requiring euthanasia at 11 weeks PI of the kittens. This constitutes the first report of a replication-competent, infectious, and pathogenic molecular clone of FIV-C. Clone FIV-C36 will facilitate dissection of the pathogenic determinants of FIV.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15308694      PMCID: PMC506922          DOI: 10.1128/JVI.78.17.8971-8982.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

1.  The feline immunodeficiency virus ORF-A gene facilitates efficient viral replication in established T-cell lines and peripheral blood lymphocytes.

Authors:  K Tomonaga; T Miyazawa; J Sakuragi; T Mori; A Adachi; T Mikami
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  HIV-1 structural gene expression requires binding of the Rev trans-activator to its RNA target sequence.

Authors:  M H Malim; L S Tiley; D F McCarn; J R Rusche; J Hauber; B R Cullen
Journal:  Cell       Date:  1990-02-23       Impact factor: 41.582

4.  Molecular cloning of a novel isolate of feline immunodeficiency virus biologically and genetically different from the original U.S. isolate.

Authors:  T Miyazawa; M Fukasawa; A Hasegawa; N Maki; K Ikuta; E Takahashi; M Hayami; T Mikami
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

5.  Posttranscriptional effector domains in the Rev proteins of feline immunodeficiency virus and equine infectious anemia virus.

Authors:  V A Mancuso; T J Hope; L Zhu; D Derse; T Phillips; T G Parslow
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

6.  Identification of a feline immunodeficiency virus gene which is essential for cell-free virus infectivity.

Authors:  K Tomonaga; J Norimine; Y S Shin; M Fukasawa; T Miyazawa; A Adachi; T Toyosaki; Y Kawaguchi; C Kai; T Mikami
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

7.  Identification of the Rev transactivation and Rev-responsive elements of feline immunodeficiency virus.

Authors:  T R Phillips; C Lamont; D A Konings; B L Shacklett; C A Hamson; P A Luciw; J H Elder
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

8.  Evolution of structural proteins of feline immunodeficiency virus: molecular epidemiology and evidence of selection for change.

Authors:  M A Rigby; E C Holmes; M Pistello; A Mackay; A J Brown; J C Neil
Journal:  J Gen Virol       Date:  1993-03       Impact factor: 3.891

9.  Regulation of gene expression directed by the long terminal repeat of the feline immunodeficiency virus.

Authors:  E E Sparger; B L Shacklett; L Renshaw-Gegg; P A Barry; N C Pedersen; J H Elder; P A Luciw
Journal:  Virology       Date:  1992-03       Impact factor: 3.616

10.  Identification of three feline immunodeficiency virus (FIV) env gene subtypes and comparison of the FIV and human immunodeficiency virus type 1 evolutionary patterns.

Authors:  D L Sodora; E G Shpaer; B E Kitchell; S W Dow; E A Hoover; J I Mullins
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

View more
  31 in total

Review 1.  Evolution of feline immunodeficiency virus in Felidae: implications for human health and wildlife ecology.

Authors:  Jill Pecon-Slattery; Jennifer L Troyer; Warren E Johnson; Stephen J O'Brien
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046

2.  Feline Immunodeficiency Virus Vif N-Terminal Residues Selectively Counteract Feline APOBEC3s.

Authors:  Qinyong Gu; Zeli Zhang; Lucía Cano Ortiz; Ana Cláudia Franco; Dieter Häussinger; Carsten Münk
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

3.  Prevention of immunodeficiency virus induced CD4+ T-cell depletion by prior infection with a non-pathogenic virus.

Authors:  Julie A Terwee; Jennifer K Carlson; Wendy S Sprague; Kerry S Sondgeroth; Sarah B Shropshire; Jennifer L Troyer; Sue VandeWoude
Journal:  Virology       Date:  2008-05-22       Impact factor: 3.616

4.  Accessory genes confer a high replication rate to virulent feline immunodeficiency virus.

Authors:  Ryan M Troyer; Jesse Thompson; John H Elder; Sue VandeWoude
Journal:  J Virol       Date:  2013-05-08       Impact factor: 5.103

5.  FIV diversity: FIV Ple subtype composition may influence disease outcome in African lions.

Authors:  Jennifer L Troyer; Melody E Roelke; Jillian M Jespersen; Natalie Baggett; Valerie Buckley-Beason; Dan MacNulty; Meggan Craft; Craig Packer; Jill Pecon-Slattery; Stephen J O'Brien
Journal:  Vet Immunol Immunopathol       Date:  2011-06-12       Impact factor: 2.046

Review 6.  Going wild: lessons from naturally occurring T-lymphotropic lentiviruses.

Authors:  Sue VandeWoude; Cristian Apetrei
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

Review 7.  Molecular mechanisms of FIV infection.

Authors:  John H Elder; Magnus Sundstrom; Sohela de Rozieres; Aymeric de Parseval; Chris K Grant; Ying-Chuan Lin
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046

8.  Enforced covalent trimerisation of soluble feline CD134 (OX40)-ligand generates a functional antagonist of feline immunodeficiency virus.

Authors:  Brian J Willett; Elizabeth L McMonagle; Nicola Logan; Pascal Schneider; Margaret J Hosie
Journal:  Mol Immunol       Date:  2009-02-01       Impact factor: 4.407

9.  Feline models of viral pathogenesis: opportunity knocks.

Authors:  Jennifer L Troyer; Meredith A Brown
Journal:  Vet J       Date:  2010-08-15       Impact factor: 2.688

10.  Multivariate statistical analyses demonstrate unique host immune responses to single and dual lentiviral infection.

Authors:  Sunando Roy; Jennie Lavine; Francesca Chiaromonte; Julie Terwee; Sue VandeWoude; Ottar Bjornstad; Mary Poss
Journal:  PLoS One       Date:  2009-10-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.